Article Details
Retrieved on: 2025-07-11 15:18:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Absci uses GenAI to unlock the potential of building treatments for elusive targets. Hear how the company integrates monoclonal antibodies (mAbs) ...
Article found on: www.tdsecurities.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here